Aerie Pharmaceuticals AERI

$ 15.25 0.0%

Quarterly report 2022-Q3
added 12-23-2023

Aerie Pharmaceuticals Balance Sheet 2011-2024 | AERI

Annual Balance Sheet Aerie Pharmaceuticals

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-11.1 M	63.7 M	50.2 M	-	-73.7 M	-74.4 M	32.2 M	38.6 M	-69.6 M	-594 K	-15.1 M
Long Term Debt	21.8 M	210 M	189 M	-	124 M	124 M	123 M	124 M	-	-	-
Long Term Debt Current	4.36 M	4.92 M	5.5 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	274 M	202 M	6.45 M	129 M	124 M	123 M	124 M	-	2.46 M	1.1 M
Total Current Liabilities	125 M	104 M	83.6 M	50.8 M	25.2 M	19.4 M	17.1 M	8.89 M	3.48 M	-	-
Total Liabilities	449 M	378 M	286 M	57.2 M	155 M	143 M	140 M	133 M	3.48 M	6.24 M	3.81 M
Deferred Revenue	85.4 M	50.9 M	-	-	-	-	-	-	-	-	-
Retained Earnings	-1.15 B	-1.08 B	-896 M	-696 M	-462 M	-317 M	-218 M	-143 M	-95.1 M	-63.9 M	-48.8 M
Total Assets	431 M	402 M	453 M	285 M	290 M	248 M	159 M	161 M	70.5 M	3.22 M	15.5 M
Cash and Cash Equivalents	37.2 M	152 M	144 M	203 M	198 M	198 M	91.1 M	85.6 M	69.6 M	2.92 M	15.1 M
Book Value	-17.3 M	24 M	167 M	228 M	136 M	105 M	18.8 M	28 M	67 M	-3.02 M	11.7 M
Total Shareholders Equity	-17.3 M	24 M	167 M	228 M	136 M	105 M	18.8 M	28 M	67 M	-63.9 M	-48.7 M

All numbers in USD currency

Quarterly Balance Sheet Aerie Pharmaceuticals

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	21 M	21.8 M	22.5 M	10 M	9.91 M	10.2 M	10.2 M	10.2 M	10.2 M	12.1 M	12.1 M	12.1 M	12.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	540 M	526 M	521 M	449 M	425 M	395 M	373 M	378 M	307 M	295 M	285 M	286 M	286 M	286 M	286 M	57.2 M	57.2 M	57.2 M	57.2 M	155 M	155 M	155 M	155 M	143 M	143 M	143 M	143 M	140 M	140 M	140 M	140 M	132 M	133 M	133 M	133 M	3.48 M	3.48 M	3.48 M	3.48 M	6.24 M	6.24 M	-	-	-	-	-	-
Deferred Revenue	-	-	-	79.2 M	85.4 M	79.8 M	73.7 M	61.5 M	66.6 M	66.6 M	66.6 M	66.6 M	38.4 M	38.4 M	38.4 M	38.4 M	10.2 M	10.2 M	10.2 M	10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-1.19 B	-1.16 B	-1.14 B	-1.15 B	-1.2 B	-1.16 B	-1.12 B	-1.08 B	-1.03 B	-993 M	-945 M	-896 M	-896 M	-896 M	-896 M	-696 M	-696 M	-696 M	-696 M	-462 M	-462 M	-462 M	-462 M	-317 M	-317 M	-317 M	-317 M	-218 M	-218 M	-218 M	-218 M	-143 M	-143 M	-143 M	-143 M	-95.1 M	-95.1 M	-95.1 M	-95.1 M	-63.9 M	-63.9 M	-	-	-	-	-	-
Total Assets	-	376 M	385 M	396 M	431 M	352 M	356 M	363 M	402 M	367 M	385 M	412 M	453 M	453 M	453 M	453 M	285 M	285 M	285 M	285 M	290 M	290 M	290 M	290 M	248 M	248 M	248 M	248 M	159 M	159 M	159 M	159 M	160 M	161 M	161 M	161 M	70.5 M	70.5 M	70.5 M	70.5 M	3.22 M	3.22 M	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	-	56.4 M	37.2 M	61.8 M	80 M	123 M	152 M	152 M	152 M	152 M	144 M	144 M	144 M	144 M	203 M	203 M	203 M	203 M	198 M	198 M	198 M	198 M	198 M	198 M	198 M	198 M	91.1 M	91.1 M	91.1 M	91.1 M	85.6 M	85.6 M	85.6 M	85.6 M	69.6 M	69.6 M	69.6 M	69.6 M	2.92 M	2.92 M	-	-	15.1 M	-	-	-
Book Value	-	-164 M	-141 M	-126 M	-17.3 M	-72.9 M	-39.6 M	-10.4 M	24 M	60.1 M	89.8 M	127 M	167 M	167 M	167 M	167 M	228 M	228 M	228 M	228 M	136 M	136 M	136 M	136 M	105 M	105 M	105 M	105 M	18.8 M	18.8 M	18.8 M	18.8 M	28 M	28 M	28 M	28 M	67 M	67 M	67 M	67 M	-3.02 M	-3.02 M	-	-	-	-	-	-
Total Shareholders Equity	-	-164 M	-141 M	-126 M	-17.3 M	-72.9 M	-39.6 M	-10.4 M	24 M	60.1 M	89.8 M	127 M	167 M	209 M	167 M	167 M	228 M	228 M	228 M	228 M	136 M	136 M	136 M	136 M	105 M	105 M	105 M	105 M	18.8 M	18.8 M	18.8 M	18.8 M	28 M	28 M	28 M	28 M	67 M	67 M	67 M	67 M	-63.9 M	-63.9 M	-	-	-48.7 M	-	-	-

All numbers in USD currency